Chimerix stock symbol

WebFeb 17, 2024 · Every investor in Chimerix, Inc. (NASDAQ:CMRX) should be aware of the most powerful shareholder groups.We can see that institutions own the lion's share in the company with 53% ownership. In other ... WebChimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox.

Chimerix - Crunchbase Company Profile & Funding

WebMar 3, 2024 · Chimerix (CMRX) Stock Plummets 60% After Q1 Earnings Disappointment. By William White, InvestorPlace Writer May 16, 2024. Chimerix (CMRX) stock is falling hard on Monday following the release of ... WebFeb 8, 2024 · Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute... dunn county healthcare https://frmgov.org

CMRX Chimerix Inc. Stock Price & News - WSJ

WebCMRX Complete Chimerix Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebApr 6, 2024 · Chimerix, Inc. is a biotechnology company. The Company is focused on developing medicines that address unmet medical needs. The Company's product Imipridones is a cancer therapy that provides ONC201, which is in clinical-stage development for H3 K27M-mutant glioma as its lead indication. WebChimerix, Inc. (CMRX) Stock Price, News, Quote & History - Yahoo Finance Dow 30 Chimerix, Inc. (CMRX) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 1.2000 -0.0100... Find the latest Chimerix, Inc. (CMRX) stock discussion in Yahoo Finance's forum. … Chimerix, Inc. 2505 Meridian Parkway Suite 100 Durham, NC 27713 United States … Get the detailed quarterly/annual income statement for Chimerix, Inc. (CMRX). … Discover historical prices for CMRX stock on Yahoo Finance. View daily, weekly or … Find out all the key statistics for Chimerix, Inc. (CMRX), including valuation … See Chimerix, Inc. (CMRX) Environment, Social and Governance Ratings to help … See Chimerix, Inc. (CMRX) stock analyst estimates, including earnings and … Find out the direct holders, institutional holders and mutual fund holders for … Find the latest Chimerix, Inc. (CMRX) stock quote, history, news and other vital … Find the latest Chimerix, Inc. (CMRX) stock quote, history, news and other vital … dunn county health dept

CMRX Chimerix Inc. Stock Price & News - WSJ

Category:CMRX - Chimerix Inc Stock Price Quote - NASDAQ Morningstar

Tags:Chimerix stock symbol

Chimerix stock symbol

CMRX Stock Forecast, Price & News (Chimerix) - MarketBeat

WebFind the latest Institutional Holdings data for Chimerix, Inc. Common Stock (CMRX) at Nasdaq.com. Web18 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Chimerix (CMRX) ... Chimerix (CMRX) (Real Time Quote from BATS) $1.24 USD. 1.24 ...

Chimerix stock symbol

Did you know?

WebCMRX - Chimerix, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Daily Draw Fullscreen Settings CMRX - Stock Price Chart CMRX [NASD] Chimerix, Inc. Healthcare Biotechnology USA WebMar 31, 2024 · What were Chimerix’s (NASDAQ:CMRX) revenues? A. The Actual Revenue was $1.8M, which beat the estimate of $870K. Browse earnings estimates, EPS, and revenue on all stocks.

WebMar 2, 2024 · Find the latest Earnings Report Date for Chimerix, Inc. Common Stock (CMRX) at Nasdaq.com. WebApr 7, 2024 · Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute...

WebApr 6, 2024 · Ticker Symbol CMRX Full Company Profile Financial Performance Financial Statements Analyst Forecast According to 12 analysts, the average rating for CMRX stock is "Buy." The 12-month stock price forecast is $7.48, which is an increase of 493.65% from the latest price. Price Target $7.48 ( 493.65% upside) Analyst Consensus: Buy Stock … WebApr 11, 2024 · Chimerix (NASDAQ:CMRX) has a market capitalization of $105.92 million and generates $33.82 million in revenue each year. The biopharmaceutical company earns $172.17 million in net income (profit) …

WebView the latest Chimerix Inc. (CMRX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

WebMay 16, 2024 · A poorly received decision from the management team at Chimerix (NASDAQ: CMRX), a biopharmaceutical company, sent its stock price into a nosedive on Monday morning. Investors furious about the ... dunn county housingWebFind the latest Institutional Holdings data for Chimerix, Inc. Common Stock (CMRX) at Nasdaq.com. Chimerix, Inc. Common Stock (CMRX) Institutional Holdings Nasdaq Skip to main content dunn county home and gardenWebChimerix (CMRX) Loses -24.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner. Chimerix (CMRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a … dunn county historical society ndWebThe 6 analysts offering 12-month price forecasts for Chimerix Inc have a median target of 6.50, with a high estimate of 11.00 and a low estimate of 5.00. The median estimate represents a +432.79% ... dunn county jail menomonie wiWebStock Price Forecast. The 6 analysts offering 12-month price forecasts for Chimerix Inc have a median target of 6.50, with a high estimate of 11.00 and a low estimate of 5.00. The median estimate ... dunn county housing assistanceWebDiscover historical prices for CMRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Chimerix, Inc. stock was issued. dunn county nd auditorWebChimerix stock surges after deal to sell smallpox treatment Tembexa for up to $337.5 million, plus royalties. MarketWatch. 06:32AM. Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages. dunn county jail roster